Abbott today announced it has received CE Mark in Europe for the Volttm PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has begun ...
In February, researchers from conservation organisation Condrik Tenerife were about two kilometres off the coast of Tenerife ...
On Sept. 6, 2024, Lev'Veon became the first child in Michigan to get a total artificial heart, and he is possibly the ...
Experts discuss their experience using Philips LumiGuide; the value of 3D, color visualization; the learning curve; and its ...
Pulse Biosciences, Inc. ( NASDAQ: PLSE) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Philip Trip Taylor - Investor Relations Paul LaViolette - Chief Executive Officer and Co-Chairman of ...
Vietnam Investment Review on MSN1d
Supira Medical Raises $120M in Oversubscribed Series E, Completes SUPPORT I Study Enrollment in the U.S.Supira Medical, Inc., today announced the successful completion of an oversubscribed Series E financing round, raising $120M ...
Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an ...
Medtronic’s VenaSeal Spectrum postmarket clinical trial program is highlighting the need for further patient-centric ...
Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR breakthroughs and is entering commercialization stage for its TAVR (AR) product ...
Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with TTVR ...
I was particularly interested in medical errors, believed to be the third leading cause of death in the United States, as well as the surprising complexities of diagnosis, an opaque process sometimes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback